These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 18362365)

  • 61. Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches.
    Buck AK; Herrmann K; Stargardt T; Dechow T; Krause BJ; Schreyögg J
    J Nucl Med; 2010 Mar; 51(3):401-12. PubMed ID: 20150250
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Advanced imaging modalities in early stage breast cancer: preoperative use in the United States Medicare population.
    Crivello ML; Ruth K; Sigurdson ER; Egleston BL; Evers K; Wong YN; Boraas M; Bleicher RJ
    Ann Surg Oncol; 2013 Jan; 20(1):102-10. PubMed ID: 22878617
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparing physician-reported cancer management plans with Medicare services received.
    Henderson LM; Reeder-Hayes K; Hinton SP; Carpenter WR; Chen RC
    Arch Intern Med; 2012 Apr; 172(8):664-6. PubMed ID: 22529235
    [No Abstract]   [Full Text] [Related]  

  • 64. [Positron emission tomography (PET)--current state of the art and future perspectives].
    von Schulthess GK;
    Praxis (Bern 1994); 2005 Aug; 94(35):1331-7. PubMed ID: 16171004
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Positron emission tomography 2013 in Germany. Results of the query and current status].
    Kotzerke J; Oehme L; Grosse J; Hellwig D;
    Nuklearmedizin; 2015; 54(2):53-9. PubMed ID: 25650552
    [TBL] [Abstract][Full Text] [Related]  

  • 66. PET scan in clinically suspected paraneoplastic neurological syndromes: a 6-year prospective study in a regional neuroscience unit.
    Hadjivassiliou M; Alder SJ; Van Beek EJ; Hanney MB; Lorenz E; Rao DG; Sharrack B; Tindale WB
    Acta Neurol Scand; 2009 Mar; 119(3):186-93. PubMed ID: 18855873
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Positron emission tomography: current status and future challenges.
    Lin M; Shon IH; Lin P
    Intern Med J; 2010 Jan; 40(1):19-29. PubMed ID: 20561362
    [TBL] [Abstract][Full Text] [Related]  

  • 68. HCFA approves Medicare coverage of PET scans.
    Cave L
    J Natl Cancer Inst; 2001 Feb; 93(3):177. PubMed ID: 11158185
    [No Abstract]   [Full Text] [Related]  

  • 69. [Diagnostic imaging studies: do they create anxiety?].
    Pifarré P; Simó M; Gispert JD; Pallarés MD; Plaza P; Martínez-Miralles E
    Rev Esp Med Nucl; 2011; 30(6):346-50. PubMed ID: 21764482
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical PET/CT imaging: promises and misconceptions.
    Czernin J; Auerbach MA
    Nuklearmedizin; 2005; 44 Suppl 1():S18-23. PubMed ID: 16395974
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Positron emission tomography (PET) in oncology: a part of medical therapeutic expertise].
    Bamberg M; Diehl V; Herrmann T; Jürgens H; Siewert JR; Kotzerke J;
    Dtsch Med Wochenschr; 2006 Mar; 131(10):512-5. PubMed ID: 16511743
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The usefulness of positron emission tomography in evaluating patients for pulmonary malignancies.
    McCain TW; Dunagan DP; Chin R; Oaks T; Harkness BA; Haponik EF
    Chest; 2000 Dec; 118(6):1610-5. PubMed ID: 11115447
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Quantitative imaging in oncology patients: Part 1, radiology practice patterns at major U.S. cancer centers.
    Jaffe TA; Wickersham NW; Sullivan DC
    AJR Am J Roentgenol; 2010 Jul; 195(1):101-6. PubMed ID: 20566802
    [TBL] [Abstract][Full Text] [Related]  

  • 74. PET coverage extended. Medicare won't stop covering post-treatment scans.
    Zigmond J
    Mod Healthc; 2013 Jun; 43(24):24. PubMed ID: 23875236
    [No Abstract]   [Full Text] [Related]  

  • 75. CMS and PET for solid tumors.
    Cannon H
    J Nucl Med; 2008 Dec; 49(12):23N. PubMed ID: 19038994
    [No Abstract]   [Full Text] [Related]  

  • 76. Value of Positron Emission Tomography/Computed Tomography (PET-CT) in Suspected Non-small Cell Lung Cancer Recurrence and Impact on Patient Management.
    Beslic N; Sadija A; Ceric T; Milardovic R; Ceric S; Cavaljuga S
    Acta Inform Med; 2016 Jul; 24(4):296-298. PubMed ID: 27708496
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Second-opinion interpretations of neuroimaging studies by oncologic neuroradiologists can help reduce errors in cancer care.
    Hatzoglou V; Omuro AM; Haque S; Khakoo Y; Ganly I; Oh JH; Shukla-Dave A; Fatovic R; Gaal J; Holodny AI
    Cancer; 2016 Sep; 122(17):2708-14. PubMed ID: 27219108
    [TBL] [Abstract][Full Text] [Related]  

  • 78. 2014 Cassen Lecture: What have we learned from the National Oncologic PET Registry?
    Siegel BA
    J Nucl Med; 2014 Dec; 55(12):9N-15N. PubMed ID: 25453061
    [No Abstract]   [Full Text] [Related]  

  • 79. Test limits meet resistance: CMS seeks to restrict new PET scans for Alzheimer's.
    Lee J
    Mod Healthc; 2013 Jul; 43(27):4. PubMed ID: 23878914
    [No Abstract]   [Full Text] [Related]  

  • 80. Clinical utility of positron emission tomography/computed tomography in inflammatory bowel disease.
    Lapp RT; Spier BJ; Perlman SB; Jaskowiak CJ; Reichelderfer M
    Mol Imaging Biol; 2011 Jun; 13(3):573-576. PubMed ID: 20574849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.